ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 11 filers reported holding ANEBULO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,978 | +42.5% | 18,978 | +9.6% | 0.00% | 0.0% |
| Q2 2023 | $40,700 | -19.0% | 17,319 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $50,225 | +19.7% | 17,319 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $41,976 | -12.6% | 17,319 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $48,000 | -46.7% | 17,319 | -0.1% | 0.00% | -50.0% |
| Q2 2022 | $90,000 | -26.8% | 17,333 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $123,000 | +11.8% | 17,333 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $110,000 | -3.5% | 17,333 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $114,000 | -15.6% | 17,333 | -12.6% | 0.00% | -25.0% |
| Q2 2021 | $135,000 | – | 19,835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 5,066,290 | $15,477,516 | 11.03% |
| LVW Advisors, LLC | 672,331 | $2,053,972 | 0.42% |
| Praetorian PR LLC | 177,292 | $541,627 | 0.28% |
| Nantahala Capital Management | 511,073 | $1,561,328 | 0.13% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $1,219,614 | 0.09% |
| Ikarian Capital, LLC | 157,862 | $503,580 | 0.06% |
| Tower Research Capital LLC (TRC) | 20,851 | $63,700 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,978 | $57,978 | 0.00% |
| ROYAL BANK OF CANADA | 48 | $0 | 0.00% |
| VANGUARD GROUP INC | 22,344 | $68,261 | 0.00% |